Literature DB >> 21602576

Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia.

David Leitsch1, Anita G Burgess, Linda A Dunn, Kenia G Krauer, Kevin Tan, Michael Duchêne, Peter Upcroft, Lars Eckmann, Jacqueline A Upcroft.   

Abstract

OBJECTIVES: The mechanism of action of, and resistance to, metronidazole in the anaerobic (or micro-aerotolerant) protozoan parasite Giardia lamblia has long been associated with the reduction of ferredoxin (Fd) by the enzyme pyruvate:ferredoxin oxidoreductase (PFOR) and the subsequent activation of metronidazole by Fd to toxic radical species. Resistance to metronidazole has been associated with down-regulation of PFOR and Fd. The aim of this study was to determine whether the PFOR/Fd couple is the only pathway involved in metronidazole activation in Giardia.
METHODS: PFOR and Fd activities were measured in extracts of highly metronidazole-resistant (MTR(r)) lines and activities of recombinant G. lamblia thioredoxin reductase (GlTrxR) and NADPH oxidase were assessed for their involvement in metronidazole activation and resistance.
RESULTS: We demonstrated that several lines of highly MTR(r) G. lamblia have fully functional PFOR and Fd indicating that PFOR/Fd-independent mechanisms are involved in metronidazole activation and resistance in these cells. Flavin-dependent GlTrxR, like TrxR of other anaerobic protozoa, reduces 5-nitroimidazole compounds including metronidazole, although expression of TrxR is not decreased in MTR(r) Giardia. However, reduction of flavins is suppressed in highly MTR(r) cells, as evidenced by as much as an 80% decrease in NADPH oxidase flavin mononucleotide reduction activity. This suppression is consistent with generalized impaired flavin metabolism in highly MTR(r) Trichomonas vaginalis.
CONCLUSIONS: These data add to the mounting evidence against the dogma that PFOR/Fd is the only couple with a low enough redox potential to reduce metronidazole in anaerobes and point to the multi-factorial nature of metronidazole resistance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602576      PMCID: PMC3133484          DOI: 10.1093/jac/dkr192

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  53 in total

1.  A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro.

Authors:  Linda A Dunn; Anita G Burgess; Kenia G Krauer; Lars Eckmann; Patrice Vanelle; Maxime D Crozet; Frances D Gillin; Peter Upcroft; Jacqueline A Upcroft
Journal:  Int J Antimicrob Agents       Date:  2010-04-24       Impact factor: 5.283

2.  Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

Authors:  Janelle M Wright; Linda A Dunn; Zygmunt Kazimierczuk; Anita G Burgess; Kenia G Krauer; Peter Upcroft; Jacqueline A Upcroft
Journal:  Parasitol Res       Date:  2010-06-09       Impact factor: 2.289

3.  Drug resistance in Giardia: clinical versus laboratory isolates.

Authors:  P Upcroft
Journal:  Drug Resist Updat       Date:  1998       Impact factor: 18.500

4.  Metabolism of a 5-nitroimidazole in susceptible and resistant isogenic strains of Bacteroides fragilis.

Authors:  J P Carlier; N Sellier; M N Rager; G Reysset
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 5.  Nitroimidazole drugs--action and resistance mechanisms. I. Mechanisms of action.

Authors:  D I Edwards
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

6.  A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides.

Authors:  Joachim Müller; Jonathan Wastling; Sanya Sanderson; Norbert Müller; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

Review 7.  Pathophysiology of enteric infections with Giardia duodenalius.

Authors:  A G Buret
Journal:  Parasite       Date:  2008-09       Impact factor: 3.000

8.  Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia.

Authors:  Carlos A Valdez; Jonathan C Tripp; Yukiko Miyamoto; Jaroslaw Kalisiak; Petr Hruz; Yolanda S Andersen; Sabrina E Brown; Karina Kangas; Leo V Arzu; Barbara J Davids; Frances D Gillin; Jacqueline A Upcroft; Peter Upcroft; Valery V Fokin; Diane K Smith; K Barry Sharpless; Lars Eckmann
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

9.  Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pylori.

Authors:  Igor N Olekhnovich; Avery Goodwin; Paul S Hoffman
Journal:  FEBS J       Date:  2009-05-07       Impact factor: 5.542

10.  Overexpression of the rhamnose catabolism regulatory protein, RhaR: a novel mechanism for metronidazole resistance in Bacteroides thetaiotaomicron.

Authors:  Ekta H Patel; Lynthia V Paul; Ana I Casanueva; Sheila Patrick; Valerie R Abratt
Journal:  J Antimicrob Chemother       Date:  2009-06-13       Impact factor: 5.790

View more
  41 in total

1.  Development of metronidazole-resistant lines of Blastocystis sp.

Authors:  L A Dunn; K S W Tan; P Vanelle; T Juspin; M D Crozet; T Terme; P Upcroft; J A Upcroft
Journal:  Parasitol Res       Date:  2012-02-24       Impact factor: 2.289

2.  The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.

Authors:  Veronica L Cavera; Anna Volski; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2015-06       Impact factor: 4.609

Review 3.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

4.  Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia.

Authors:  Noa Tejman-Yarden; Maya Millman; Tineke Lauwaet; Barbara J Davids; Frances D Gillin; Linda Dunn; Jacqueline A Upcroft; Yukiko Miyamoto; Lars Eckmann
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

5.  Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia.

Authors:  Wan Jung Kim; Keith A Korthals; Suhua Li; Christine Le; Jarosław Kalisiak; K Barry Sharpless; Valery V Fokin; Yukiko Miyamoto; Lars Eckmann
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

6.  A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.

Authors:  Noa Tejman-Yarden; Yukiko Miyamoto; David Leitsch; Jennifer Santini; Anjan Debnath; Jiri Gut; James H McKerrow; Sharon L Reed; Lars Eckmann
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

7.  Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity.

Authors:  Yukiko Miyamoto; Jaroslaw Kalisiak; Keith Korthals; Tineke Lauwaet; Dae Young Cheung; Ricardo Lozano; Eduardo R Cobo; Peter Upcroft; Jacqueline A Upcroft; Douglas E Berg; Frances D Gillin; Valery V Fokin; K Barry Sharpless; Lars Eckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

8.  Treatment of giardiasis: current status and future directions.

Authors:  Richard R Watkins; Lars Eckmann
Journal:  Curr Infect Dis Rep       Date:  2014-02       Impact factor: 3.725

9.  Trichomonas vaginalis flavin reductase 1 and its role in metronidazole resistance.

Authors:  David Leitsch; Brian D Janssen; Daniel Kolarich; Patricia J Johnson; Michael Duchêne
Journal:  Mol Microbiol       Date:  2013-11-20       Impact factor: 3.501

10.  Nitroimidazole drugs vary in their mode of action in the human parasite Giardia lamblia.

Authors:  David Leitsch; Sarah Schlosser; Anita Burgess; Michael Duchêne
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-05-12       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.